BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35873129)

  • 1. Delta Increment in Pacing QRS Duration Predicts Cardiovascular Mortality in Patients with Pre-Existing Bundle Branch Block Receiving Permanent Pacemakers.
    Chen HC; Liu WH; Tseng CH; Chen YL; Lee WC; Fang YN; Chong SZ; Chen MC
    Acta Cardiol Sin; 2022 Jul; 38(4):504-515. PubMed ID: 35873129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.
    Rampat R; Khawaja MZ; Hilling-Smith R; Byrne J; MacCarthy P; Blackman DJ; Krishnamurthy A; Gunarathne A; Kovac J; Banning A; Kharbanda R; Firoozi S; Brecker S; Redwood S; Bapat V; Mullen M; Aggarwal S; Manoharan G; Spence MS; Khogali S; Dooley M; Cockburn J; de Belder A; Trivedi U; Hildick-Smith D
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1247-1253. PubMed ID: 28641846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Left Ventricular Conduction Delay on All-Cause and Cardiovascular Mortality (from the PRECISION Trial).
    Kiehl EL; Menon V; Mandsager KT; Wolski KE; Wisniewski L; Nissen SE; Lincoff AM; Borer JS; Lüscher TF; Cantillon DJ
    Am J Cardiol; 2019 Oct; 124(7):1049-1055. PubMed ID: 31395295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival.
    Wokhlu A; Rea RF; Asirvatham SJ; Webster T; Brooke K; Hodge DO; Wiste HJ; Dong Y; Hayes DL; Cha YM
    Heart Rhythm; 2009 Oct; 6(10):1439-47. PubMed ID: 19717348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scar burden, not intraventricular conduction delay pattern, is associated with outcomes in ischemic cardiomyopathy patients receiving cardiac resynchronization therapy.
    Adelstein EC; Althouse AD; Schwartzman D; Jain SK; Soman P; Saba S
    Heart Rhythm; 2018 Nov; 15(11):1664-1672. PubMed ID: 29852239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECG parameters predict left ventricular conduction delay in patients with left ventricular dysfunction.
    Pastore G; Maines M; Marcantoni L; Zanon F; Noventa F; Corbucci G; Baracca E; Aggio S; Picariello C; Lanza D; Rigatelli G; Carraro M; Roncon L; Barold SS
    Heart Rhythm; 2016 Dec; 13(12):2289-2296. PubMed ID: 27424074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy in non-left bundle branch block morphologies.
    Rickard J; Kumbhani DJ; Gorodeski EZ; Baranowski B; Wazni O; Martin DO; Grimm R; Wilkoff BL
    Pacing Clin Electrophysiol; 2010 May; 33(5):590-5. PubMed ID: 20025703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronisation therapy in patients with left bundle branch block with residual conduction.
    Grebmer C; Friedrich L; Semmler V; Kottmaier M; Bourier F; Brkic A; Blazek P; Weigand S; Connor MO; Deisenhofer I; Hessling G; Kolb C; Lennerz C
    Indian Pacing Electrophysiol J; 2021; 21(1):14-17. PubMed ID: 33212244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Baseline Right Bundle Branch Block in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Auffret V; Webb JG; Eltchaninoff H; Muñoz-García AJ; Himbert D; Tamburino C; Nombela-Franco L; Nietlispach F; Morís C; Ruel M; Dager AE; Serra V; Cheema AN; Amat-Santos IJ; de Brito FS; Lemos PA; Abizaid A; Sarmento-Leite R; Dumont E; Barbanti M; Durand E; Alonso Briales JH; Vahanian A; Bouleti C; Immè S; Maisano F; Del Valle R; Benitez LM; García Del Blanco B; Puri R; Philippon F; Urena M; Rodés-Cabau J
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1564-1574. PubMed ID: 28734885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry.
    Lund LH; Benson L; Ståhlberg M; Braunschweig F; Edner M; Dahlström U; Linde C
    Eur J Heart Fail; 2014 Oct; 16(10):1073-81. PubMed ID: 25201219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients.
    Okin PM; Kjeldsen SE; Devereux RB
    J Hypertens; 2019 Mar; 37(3):629-635. PubMed ID: 30676480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: analysis of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Aranda JM; Conti JB; Johnson JW; Petersen-Stejskal S; Curtis AB
    Clin Cardiol; 2004 Dec; 27(12):678-82. PubMed ID: 15628109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
    Cannon JA; Shen L; Jhund PS; Anand IS; Komajda M; McKelvie RS; Zile MR; Carson PE; McMurray JJ
    Eur J Heart Fail; 2016 Aug; 18(8):1021-31. PubMed ID: 27194023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bundle branch blocks and the risk of mortality in the Atherosclerosis Risk in Communities study.
    Zhang ZM; Rautaharju PM; Prineas RJ; Loehr L; Rosamond W; Soliman EZ
    J Cardiovasc Med (Hagerstown); 2016 Jun; 17(6):411-7. PubMed ID: 25575277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. True complete left bundle branch block morphology strongly predicts good response to cardiac resynchronization therapy.
    Tian Y; Zhang P; Li X; Gao Y; Zhu T; Wang L; Li D; Wang J; Yuan C; Guo J
    Europace; 2013 Oct; 15(10):1499-506. PubMed ID: 23468351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE.
    Kristensen SL; Castagno D; Shen L; Jhund PS; Docherty KF; Rørth R; Abraham WT; Desai AS; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
    Eur J Heart Fail; 2020 Dec; 22(12):2370-2379. PubMed ID: 32720404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Resynchronization Defibrillator Therapy for Nonspecific Intraventricular Conduction Delay Versus Right Bundle Branch Block.
    Kawata H; Bao H; Curtis JP; Minges KE; Mitiku T; Birgersdotter-Green U; Feld GK; Hsu JC
    J Am Coll Cardiol; 2019 Jun; 73(24):3082-3099. PubMed ID: 31221257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approach to discriminate left bundle branch block from nonspecific intraventricular conduction delay using pacing-induced functional left bundle branch block.
    Scholz EP; Fischer P; Lugenbiel P; Xynogalos P; Schweizer PA; Scherer D; Thomas D; Katus HA; Zitron E
    J Interv Card Electrophysiol; 2018 Dec; 53(3):347-355. PubMed ID: 30232686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy.
    Peterson PN; Greiner MA; Qualls LG; Al-Khatib SM; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Hammill BG; Piccini JP; Hernandez AF; Curtis LH; Masoudi FA
    JAMA; 2013 Aug; 310(6):617-26. PubMed ID: 23942680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A network meta-analysis and systematic review of change in QRS duration after left bundle branch pacing, His bundle pacing, biventricular pacing, or right ventricular pacing in patients requiring permanent pacemaker.
    Tokavanich N; Prasitlumkum N; Mongkonsritragoon W; Cheungpasitporn W; Thongprayoon C; Vallabhajosyula S; Chokesuwattanaskul R
    Sci Rep; 2021 Jun; 11(1):12200. PubMed ID: 34108548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.